MA56958A1 - Use of a kv7 potassium channel opener for the treatment of pain - Google Patents

Use of a kv7 potassium channel opener for the treatment of pain

Info

Publication number
MA56958A1
MA56958A1 MA56958A MA56958A MA56958A1 MA 56958 A1 MA56958 A1 MA 56958A1 MA 56958 A MA56958 A MA 56958A MA 56958 A MA56958 A MA 56958A MA 56958 A1 MA56958 A1 MA 56958A1
Authority
MA
Morocco
Prior art keywords
treatment
pain
potassium channel
channel opener
methods
Prior art date
Application number
MA56958A
Other languages
French (fr)
Inventor
Gregory N Beatch
Jr James Philip Johnson
Original Assignee
Xenon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenon Pharmaceuticals Inc filed Critical Xenon Pharmaceuticals Inc
Priority claimed from PCT/US2020/063471 external-priority patent/WO2021113757A1/en
Publication of MA56958A1 publication Critical patent/MA56958A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Selon certains modes de réalisation, la présente invention concerne des méthodes et des utilisations pour traiter la douleur chez un sujet, les méthodes comprenant l'administration par voie orale d'une quantité thérapeutiquement efficace de n-[4-(6-fluoro-3,4-dihydro-1h-isoquinolin-2-yl)-2,6-diméthylphényl]-3,3-diméthylbutanamide (composé a), au sujet nécessitant un tel traitement. La présente invention concerne également diverses méthodes améliorées de thérapie et d'administration du composé a.In some embodiments, the present invention relates to methods and uses for treating pain in a subject, the methods comprising orally administering a therapeutically effective amount of n-[4-(6-fluoro-3 ,4-dihydro-1H-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide (compound a), to the subject in need of such treatment. The present invention also relates to various improved methods of therapy and administration of compound a.

MA56958A 2019-12-06 2020-12-04 Use of a kv7 potassium channel opener for the treatment of pain MA56958A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962945093P 2019-12-06 2019-12-06
PCT/US2020/063471 WO2021113757A1 (en) 2019-12-06 2020-12-04 Use of a kv7 potassium channel opener for treating pain

Publications (1)

Publication Number Publication Date
MA56958A1 true MA56958A1 (en) 2023-02-28

Family

ID=85793853

Family Applications (1)

Application Number Title Priority Date Filing Date
MA56958A MA56958A1 (en) 2019-12-06 2020-12-04 Use of a kv7 potassium channel opener for the treatment of pain

Country Status (1)

Country Link
MA (1) MA56958A1 (en)

Similar Documents

Publication Publication Date Title
MA52569B1 (en) METHODS FOR IMPROVING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL ACTIVATOR
DK1346041T3 (en) Therapeutic agents and methods for their use in the treatment of an amyloidogenic disease
MA27908A1 (en) THERAPEUTIC AGENTS USEFUL FOR THE TREATMENT OF PAIN
TNSN01053A1 (en) NOVEL COMPOSITIONS COMPRISING A PARTIAL NICOTINE RECEPTOR AGONIST AND AN ANALGESIC AGENT
MA31894B1 (en) Organic compositions
MA25809A1 (en) ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS
HUP0004170A2 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
BR9707233A (en) Phenanthridines
FR2856294B1 (en) COSMETIC USE OF A COMPOSITION COMPRISING AT LEAST ONE OXAZOLIN AS AN ACTIVE INGREDIENT, AS SLIMMING AND / OR FOR PREVENTING AND / OR TREATING CELLULITE
HK1091481A1 (en) Therapeutic agents useful for treating pain
DE60226723D1 (en) DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
EA200100731A1 (en) PHENYLPHENANTHRIDINE WITH INHIBITING FDE-4 ACTIVITY
ATE254461T1 (en) TREATMENT OF EYE PAIN
BRPI0006634B8 (en) topical composition comprising feverfew extract in the treatment and prevention of inflammatory disorders
EA200100872A1 (en) COMPOSITION VALDEKOKSIBA
EA200000911A1 (en) NEW CRYSTAL FORMS OF ANTI-VIRUS COMPOUND OF BENZIMIDAZOLE
EA200201276A1 (en) ARYLMETYLAMINE DERIVATIVES FOR USE AS TRIPTASE INHIBITORS
MA56607A1 (en) Methods of treating depressive disorders
EA200200132A1 (en) SELECTIVE ANTAGONISTS OF THE RECEPTOR iGluRD FOR THE TREATMENT OF MIGRAINE
DE69518840D1 (en) N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren
DK0946157T3 (en) Topical use of kappa-opioid agonists for the treatment of eye pain
ATE318610T1 (en) ORAL COMPOSITIONS FOR TREATING SCALP DISEASES
MA27539A1 (en) NEW SYNERGISTIC COMBINATION CONTAINING ROFLUMILAST AND FORMOTEROL
ATE324112T1 (en) TOPICAL TREATMENT FOR MASTALGIA
WO2001091796A8 (en) Methods, compounds and compositions for treating gout